Metagenomi Therapeutics (MGX) Capital Expenditures (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Capital Expenditures of $125,000 for Q2 2026, down 1.6% from $127,000 a year earlier but up 400.0% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Capital Expenditures (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Metagenomi Therapeutics' Capital Expenditures came in at $309,000, down 84.1% year-over-year; for FY2025, it came in at $574,000, down 81.6% from FY2024.
- By year, Capital Expenditures came in at $3.11 million in FY2024 (-68.3%) and $9.81 million in FY2023.
- Five-year quarterly Capital Expenditures spans a low of $25,000 in Q1 2026 and a high of $3.15 million in Q2 2023.
- Year over year, Capital Expenditures has now declined in each of the last ten quarters, with an average decline of 67.3% over the last eight quarters.
- The year-over-year decline in Capital Expenditures has ranged between 1.6% (Q2 2026) and 93.8% (Q3 2025) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $25,000 (Q1 2026), $85,000 (Q4 2025) and $74,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Metagenomi Therapeutics | 30.98 Mn | -574.76 Mn | - | 125,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 85,000.00 |
| Sep 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | 288,000.00 |
| Dec 31, 2024 | 334,000.00 |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 665,000.00 |
| Mar 31, 2024 | 915,000.00 |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 2.26 Mn |
| Jun 30, 2023 | 3.15 Mn |
| Mar 31, 2023 | 2.67 Mn |
API Access
Metagenomi Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();